Chemistry Wealth Management’s Ambev ABEV Stock Holding History

Chemistry Wealth Management’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$110K	Hold	35,000	–	–	0.02%	208
2026 Q1	$102K	Hold	35,000	–	–	0.02%	201
2025 Q4	$86.5K	Hold	35,000	–	–	0.02%	198
2025 Q3	$78K	Sell	35,000 -1,618	-4%	-$3.7K	0.02%	200
2025 Q2	$88.2K	Hold	36,618	–	–	0.02%	193
2025 Q1	$85.3K	Hold	36,618	–	–	0.02%	182
2024 Q4	$67.7K	Hold	36,618	–	–	0.02%	178
2024 Q3	$89.3K	Hold	36,618	–	–	0.02%	178
2024 Q2	$75.1K	Hold	36,618	–	–	0.02%	165
2024 Q1	$90.8K	Hold	36,618	–	–	0.02%	162
2023 Q4	$103K	Hold	36,618	–	–	0.03%	150
2023 Q3	$94.5K	Hold	36,618	–	–	0.03%	143
2023 Q2	$116K	Hold	36,618	–	–	0.04%	143
2023 Q1	$103K	Hold	36,618	–	–	0.04%	140
2022 Q4	$99.6K	Buy	36,618 +1,618	+5%	+$4.71K	0.04%	137
2022 Q3	$99K	Hold	35,000	–	–	0.04%	129
2022 Q2	$88K	Hold	35,000	–	–	0.03%	133
2022 Q1	$113K	Buy	+35,000	New	+$97.8K	0.04%	137

Other funds holding ABEV

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

FRM

Foundation Resource Management Little Rock, Arkansas $860M AUM 38.08% 1-Year Est. Return

MAA

Mraz Amerine & Associates Modesto, California $697M AUM 19.37% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Sava Infond Maribor, Slovenia $1.41B AUM 69.95% 1-Year Est. Return

Oldfield Partners London, United Kingdom $415M AUM 35.18% 1-Year Est. Return

Unison Advisors Washington, District of Columbia $1.43B AUM 23.44% 1-Year Est. Return

IRC

Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Chemistry Wealth Management's ABEV Position: Q2 2026 in Review

Chemistry Wealth Management held its Ambev (ABEV) position steady in Q2 2026 at 35,000 shares worth $110K. The position accounts for 0.02% of the portfolio, ranked #208.

Chemistry Wealth Management first reported a position in ABEV in Q1 2022 and has held it in 18 quarters since. The position peaked at $116K in Q2 2023. 76 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

Chemistry Wealth Management held 35,000 shares of Ambev worth $110K as of Q2 2026.
Chemistry Wealth Management left its Ambev share count unchanged in Q2 2026.
Ambev made up 0.02% of Chemistry Wealth Management's portfolio in Q2 2026, its #208 holding.
Chemistry Wealth Management first reported a position in Ambev in Q1 2022 and has held it in 18 quarters since.
Chemistry Wealth Management's Ambev position peaked at $116K in Q2 2023.
76 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.